25,269 results match your criteria Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases[Journal]


Nobiletin Protects Against Systemic Inflammation-Stimulated Memory Impairment via MAPK and NF-κB Signaling Pathways.

J Agric Food Chem 2019 Apr 17. Epub 2019 Apr 17.

Neuroinflammation is intensively demonstrated to be related with various neurodegenerative diseases including Parkinson disease (PD), amyotrophic lateral sclerosis (ALS), and Alzheimer disease (AD). As a natural polymethoxylated flavone, Nobiletin (NOB) is reported to alleviate oxidative stress, insulin resistance, and obesity. In this study, we evaluated the protection effects of NOB on neuroinflammation and memory deficit. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jafc.9b00133DOI Listing

Misfolded SOD1 inclusions in patients with mutations in and other ALS/FTD-associated genes.

J Neurol Neurosurg Psychiatry 2019 Apr 16. Epub 2019 Apr 16.

Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden

Objective: A hallmark of amyotrophic lateral sclerosis (ALS) caused by mutations in () are inclusions containing SOD1 in motor neurons. Here, we searched for SOD1-positive inclusions in 29 patients carrying ALS-linked mutations in six other genes.

Methods: A panel of antibodies that specifically recognise misfolded SOD1 species were used for immunohistochemical investigations of autopsy tissue. Read More

View Article

Download full-text PDF

Source
http://jnnp.bmj.com/lookup/doi/10.1136/jnnp-2018-319386
Publisher Site
http://dx.doi.org/10.1136/jnnp-2018-319386DOI Listing
April 2019
1 Read

Mutations in ATP13A2 (PARK9) are associated with an amyotrophic lateral sclerosis-like phenotype, implicating this locus in further phenotypic expansion.

Hum Genomics 2019 Apr 16;13(1):19. Epub 2019 Apr 16.

Center for Human Disease Modeling, Duke University Medical Center, Carmichael Building, 300 North Duke Street, Suite 48-118, Durham, NC, 27701, USA.

Background: Amyotrophic lateral sclerosis [1] is a genetically heterogeneous neurodegenerative disorder, characterized by late-onset degeneration of motor neurons leading to progressive limb and bulbar weakness, as well as of the respiratory muscles, which is the primary cause of disease fatality. To date, over 25 genes have been implicated as causative in ALS with C9orf72, SOD1, FUS, and TARDBP accounting for the majority of genetically positive cases.

Results: We identified two patients of Italian and French ancestry with a clinical diagnosis of juvenile-onset ALS who were mutation-negative in any of the known ALS causative genes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40246-019-0203-9DOI Listing

Real-Time Performance of a Tactile Neuroprosthesis on Awake Behaving Rats.

IEEE Trans Neural Syst Rehabil Eng 2019 Apr 11. Epub 2019 Apr 11.

With the advancement of electrode and equipment technology, neuroprosthetics have become a promising alternative to partially compensate for the loss of sensorimotor function in amputees and patients with neurological diseases. Cortical neural interfaces are suitable especially for spinal cord injuries and amyotrophic lateral sclerosis. Although considerable success has been achieved in the literature by spike decoding of motor signáis from the human brain, somatosensory feedback is essential for better motor control, interaction with objects, and the embodiment of prosthetic devices. Read More

View Article

Download full-text PDF

Source
https://ieeexplore.ieee.org/document/8688479/
Publisher Site
http://dx.doi.org/10.1109/TNSRE.2019.2910320DOI Listing
April 2019
1 Read

Prognostic analysis of amyotrophic lateral sclerosis based on clinical features and plasma surface-enhanced Raman spectroscopy.

J Biophotonics 2019 Apr 15:e201900012. Epub 2019 Apr 15.

Department of Neurology and Institute of Neurology, First Affiliated Hospital, Fujian Medical University, Fuzhou, China.

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a wide range of survival times. We aimed to explore prognostic factors related to short survival based on clinical features and plasma metabolic signatures using surface-enhanced Raman spectroscopy (SERS). One hundred and thirty-eight sporadic ALS cases were enrolled serially, including 62 for the short-duration group (≤3 years) and 76 for the long-duration group (>3 years). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbio.201900012DOI Listing

Ultrasound in the Diagnosis and Monitoring of Amyotrophic Lateral Sclerosis: A Review.

Muscle Nerve 2019 Apr 16. Epub 2019 Apr 16.

Department of Neurology, Penn State Hershey Medical Center, Hershey, PA.

Neuromuscular ultrasound is complementary to electrodiagnostic (EDx) testing and is useful in enhancing the diagnosis of mononeuropathies, peripheral nerve trauma and demyelinating polyneuropathies. There is increasing interest in using ultrasound both to aid in the diagnosis of amyotrophic lateral sclerosis (ALS) and to monitor its progression. In this review, the relevant literature on ultrasound in ALS is reviewed. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/mus.26487
Publisher Site
http://dx.doi.org/10.1002/mus.26487DOI Listing
April 2019
1 Read

Microstructural correlates of Edinburgh Cognitive and Behavioural ALS Screen (ECAS) changes in amyotrophic lateral sclerosis.

Psychiatry Res Neuroimaging 2019 Apr 2. Epub 2019 Apr 2.

Department of Advanced Medical and Surgical Sciences, MRI Research Centre "SUN-FISM", University of Campania "Luigi Vanvitelli", P.zza Miraglia 2, Naples 80138, Italy.

Edinburgh Cognitive and Behavioural ALS Screen (ECAS) was designed for testing patients with amyotrophic lateral sclerosis (ALS), a multi-system neurodegenerative disease characterized by progressive physical disability. In this study, we aim to explore the potential brain microstructural substrates associated with performance on ECAS in the early stages of ALS, using a whole-brain tract-based spatial statistics diffusion tensor imaging approach. Thirty-six non-demented ALS patients, assessed using ECAS, and 35 age-, sex- and education-matched healthy controls underwent magnetic resonance imaging at 3 Tesla. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pscychresns.2019.04.001DOI Listing

Co-delivery of Plasmid and Curcumin with Mesoporous Silica Nanoparticles for Promoting Neurite Outgrowth.

ACS Appl Mater Interfaces 2019 Apr 15. Epub 2019 Apr 15.

Reactive oxygen species (ROS)-induced oxidative stress leads to neuron damage is involved in the pathogenesis of chronic inflammation in neurodegenerative diseases (NDs), such as Alzheimer's (AD), Parkinson's (PD) and amyotrophic lateral sclerosis (ALS). Researchers, therefore, are looking for anti-inflammatory drugs and gene therapy approaches to slow down or even prevent neurological disorders. Combining therapeutics have shown the synergistic effect in the treatment of human diseases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsami.9b02797DOI Listing

Rare variants in MYH15 modify amyotrophic lateral sclerosis risk.

Hum Mol Genet 2019 Apr 1. Epub 2019 Apr 1.

Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA.

Amyotrophic lateral sclerosis (ALS) is a fatal neurological disorder characterized by progressive muscular atrophy and respiratory failure. The G4C2 repeat expansion in the C9orf72 gene is the most prevalent genetic risk for ALS. Mutation carriers (C9ALS) display variability in phenotypes such as age-at-onset and duration, suggesting the existence of additional genetic factors. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddz063DOI Listing

The O-GlcNAc modification protects against protein misfolding and aggregation in neurodegenerative disease.

ACS Chem Neurosci 2019 Apr 15. Epub 2019 Apr 15.

Post-translational modifications (PTM) of proteins are becoming the focus of intense research due to their implications in a broad spectrum of neurodegenerative diseases. Various PTMs have been identified to alter the toxic profiles of proteins which play critical roles in disease etiology. In Alzheimer's disease (AD), dysregulated phosphorylation is reported to promote pathogenic processing of the microtubule-associated tau protein. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acschemneuro.9b00143DOI Listing

RNA Sequencing Reveals Small and Variable Contributions of Infectious Agents to Transcriptomes of Postmortem Nervous Tissues From Amyotrophic Lateral Sclerosis, Alzheimer's Disease and Parkinson's Disease Subjects, and Increased Expression of Genes From Disease-Activated Microglia.

Front Neurosci 2019 28;13:235. Epub 2019 Mar 28.

Parkinson's and Movement Disorders Center, Virginia Commonwealth University, Richmond, VA, United States.

Nervous tissues from both humans with neurodegenerative diseases (NDD) and animals with genetic models of human NDD, such as rare monogenic causes of Amyotrophic Lateral Sclerosis (ALS), Alzheimer's disease (AD), and Parkinson's disease (PD), show activated microglia, suggesting a potential causal role for inflammation in pathogenesis of NDD. We performed paired-end (PE) RNA sequencing (RNA seq) of total RNA's extracted from frozen sections of cervical spinal cords from ALS and CTL subjects, frontal cortical gray matter ribbons of AD and CTL subjects, and ventral midbrains of PD and CTL subjects. Trimmed PE reads were aligned against the hg38 human transcriptome using Tophat2/Bowtie2 (ALS) or HISAT2 (AD and PD) and quantitated with Cufflinks. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fnins.2019.00235DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447612PMC

Can we turn mice into men?: An Editorial for 'Effects of cannabinoids in Amyotrophic Lateral Sclerosis (ALS) murine models: a systematic review and meta-analysis' page 284.

Authors:
Albert C Ludolph

J Neurochem 2019 Apr;149(2):168-169

Department of Neurology, University of Ulm, Ulm, Germany.

The pressure to develop pharmacological therapeutic interventions in the field of the rapidly progressing, fatal disease amyotrophic lateral sclerosis (ALS) is traditionally high. Cannabinoids have been discussed for decades as potential neuroprotective agents for ALS because of their antiexcitatory, anti-inflammatory, antiapoptotic and anticatabolic properties. This Editorial highlights a study by Urbi et al in the current issue of the Journal of Neurochemistry, in which the authors performed a Systematic Review and come to the conclusion that cannabinoids seem to have a small, but consistent effect on survival and function of the G93A mice, a standard model for ALS. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jnc.14651DOI Listing

ALS-Linked Mutations Affect UBQLN2 Oligomerization and Phase Separation in a Position- and Amino Acid-Dependent Manner.

Structure 2019 Apr 4. Epub 2019 Apr 4.

Departments of Biology and Chemistry, Syracuse University, Syracuse, NY 13244, USA; Interdisciplinary Neuroscience Program, Syracuse University, Syracuse, NY 13244, USA. Electronic address:

Proteasomal shuttle factor UBQLN2 is recruited to stress granules and undergoes liquid-liquid phase separation (LLPS) into protein-containing droplets. Mutations to UBQLN2 have recently been shown to cause dominant X-linked inheritance of amyotrophic lateral sclerosis (ALS) and ALS/dementia. Interestingly, most of these UBQLN2 mutations reside in its proline-rich (Pxx) region, an important modulator of LLPS. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.str.2019.03.012DOI Listing

Post-hoc analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis.

Amyotroph Lateral Scler Frontotemporal Degener 2019 Apr 13:1-11. Epub 2019 Apr 13.

c Mitsubishi Tanabe Pharma America , Jersey City , NJ , USA , and.

Objectives: The edaravone development program established a study design in which a treatment effect slowing functional loss in amyotrophic lateral sclerosis (ALS) could be documented within a 24-week time frame. This report elucidates the strategic enrichment design utilized to create efficiency and precision in the development program.

Methods: Post-hoc analyses describe learning, sequential iteration, and evolution in study design. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21678421.2019.1599955DOI Listing

C9orf72 Poly(PR) Dipeptide Repeats Disturb Biomolecular Phase Separation and Disrupt Nucleolar Function.

Mol Cell 2019 Apr 3. Epub 2019 Apr 3.

Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Department of Microbiology, Immunology, and Biochemistry, University of Tennessee Health Sciences Center, Memphis, TN 38105, USA. Electronic address:

Repeat expansion in the C9orf72 gene is the most common cause of the neurodegenerative disorder amyotrophic lateral sclerosis (C9-ALS) and is linked to the unconventional translation of five dipeptide-repeat polypeptides (DPRs). The two enriched in arginine, poly(GR) and poly(PR), infiltrate liquid-like nucleoli, co-localize with the nucleolar protein nucleophosmin (NPM1), and alter the phase separation behavior of NPM1 in vitro. Here, we show that poly(PR) DPRs bind tightly to a long acidic tract within the intrinsically disordered region of NPM1, altering its phase separation with nucleolar partners to the extreme of forming large, soluble complexes that cause droplet dissolution in vitro. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molcel.2019.03.019DOI Listing
April 2019
1 Read

Molecular dynamics study of structure, folding, and aggregation of poly-glycine-alanine (Poly-GA).

J Chem Phys 2019 Apr;150(14):144307

Mork Family Department of Chemical Engineering and Materials Science, University of Southern California, Los Angeles, California 90089-1211, USA.

Poly-glycine-alanine (poly-GA) proteins are widely believed to be one of the main toxic dipeptide repeat molecules associated with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia diseases. Using discontinuous molecular dynamics simulation and an all-atom model of the proteins, we study folding, stability, and aggregation of poly-GA. The results demonstrate that poly-GA is an aggregation-prone protein that, after a long enough time, forms β-sheet-rich aggregates that match recent experiment data and that two unique helical structures are formed very frequently, namely, β-helix and double-helix. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1063/1.5081867DOI Listing

The potential roles of aquaporin 4 in amyotrophic lateral sclerosis.

Neurol Sci 2019 Apr 13. Epub 2019 Apr 13.

Computer Center, The Second Affiliated Hospital of Dalian Medical University, 467 Zhong Shan Road, Dalian, 116023, China.

Aquaporin 4 (AQP4) is a primary water channel found on astrocytes in the central nervous system (CNS). Besides its function in water and ion homeostasis, AQP4 has also been documented to be involved in a myriad of acute and chronic cerebral pathologies, including autoimmune neurodegenerative diseases. AQP4 has been postulated to be associated with the incidence of a progressive neurodegenerative disorder known as amyotrophic lateral sclerosis (ALS), a disease that targets the motor neurons, causing muscle weakness and eventually paralysis. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10072-019-03877-5
Publisher Site
http://dx.doi.org/10.1007/s10072-019-03877-5DOI Listing
April 2019
1 Read

The role of the protein-RNA recognition code in neurodegeneration.

Authors:
Jozef Nahalka

Cell Mol Life Sci 2019 Apr 12. Epub 2019 Apr 12.

Institute of Chemistry, Centre for Glycomics, Slovak Academy of Sciences, Dubravska cesta 9, 84538, Bratislava, Slovak Republic.

MicroRNAs are small endogenous RNAs that pair and bind to sites on mRNAs to direct post-transcriptional repression. However, there is a possibility that microRNAs directly influence protein structure and activity, and this influence can be termed post-translational riboregulation. This conceptual review explores the literature on neurodegenerative disorders. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00018-019-03096-3DOI Listing
April 2019
2 Reads

ULK1 and ULK2 Regulate Stress Granule Disassembly Through Phosphorylation and Activation of VCP/p97.

Mol Cell 2019 Apr 3. Epub 2019 Apr 3.

Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Electronic address:

Disturbances in autophagy and stress granule dynamics have been implicated as potential mechanisms underlying inclusion body myopathy (IBM) and related disorders. Yet the roles of core autophagy proteins in IBM and stress granule dynamics remain poorly characterized. Here, we demonstrate that disrupted expression of the core autophagy proteins ULK1 and ULK2 in mice causes a vacuolar myopathy with ubiquitin and TDP-43-positive inclusions; this myopathy is similar to that caused by VCP/p97 mutations, the most common cause of familial IBM. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molcel.2019.03.027DOI Listing

C9orf72 hexanucleotide repeat length in older population: normal variation and effects on cognition.

Neurobiol Aging 2019 Mar 11. Epub 2019 Mar 11.

Molecular Neurology, Research Programs Unit, Department of Neurology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.

The hexanucleotide repeat expansion in C9orf72 is a common cause of amyotrophic lateral sclerosis/frontotemporal dementia and also rarely found in other psychiatric and neurodegenerative conditions. Alleles with >30 repeats are often considered an expansion, but the pathogenic repeat length threshold is still unclear. It is also unclear whether intermediate repeat length alleles (often defined either as 7-30 or 20-30 repeats) have clinically significant effects. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neurobiolaging.2019.02.026DOI Listing

Edinburgh Cognitive and Behavioral Amyotrophic Lateral Sclerosis Screen (ECAS) in Norway: Protocol for validation and a prospective cohort study.

Contemp Clin Trials Commun 2019 Jun 18;14:100347. Epub 2019 Mar 18.

Department of Neurology, Neurologic Clinic, Haukeland University Hospital, Bergen, Norway.

In amyotrophic lateral sclerosis (ALS) cognitive impairment may occur. This could detrimentally influence communication between patient and health-care professionals and make clinical assessment difficult. Given the short life expectancy after diagnosis, it is crucial to accurately identify ALS patients early. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.conctc.2019.100347DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444026PMC
June 2019
1 Read

Loss of CREST leads to neuroinflammatory responses and ALS-like motor defects in mice.

Transl Neurodegener 2019 2;8:13. Epub 2019 Apr 2.

1Institute of Neuroscience, State Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031 China.

Background: Amyotrophic lateral sclerosis (ALS) is a late onset neurodegenerative disease with fast progression. ALS has heavy genetic components in which a series of genetic mutations have been identified. In 2013, Mutations of the gene (also known as ), which functions as a calcium-regulated transcriptional activator, were found in sporadic ALS patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40035-019-0152-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444434PMC
April 2019
3 Reads

Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosis.

Sci Rep 2019 Apr 11;9(1):5931. Epub 2019 Apr 11.

Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that affects 1 in ~350 individuals. Genetic association studies have established ALS as a multifactorial disease with heritability estimated at ~61%, and recent studies show a prominent role for rare variation in its genetic architecture. To identify rare variants associated with disease onset we performed exome array genotyping in 4,244 cases and 3,106 controls from European cohorts. Read More

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41598-019-42091-3
Publisher Site
http://dx.doi.org/10.1038/s41598-019-42091-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459905PMC
April 2019
2 Reads

Excess glutamate secreted from astrocytes drives upregulation of P-glycoprotein in endothelial cells in amyotrophic lateral sclerosis.

Exp Neurol 2019 Apr 9. Epub 2019 Apr 9.

Jefferson Weinberg ALS Center, Vickie and Jack Farber Institute for Neuroscience, Department of Neuroscience, Thomas Jefferson University, 900 Walnut Street, Philadelphia, PA 19107, USA. Electronic address:

In amyotrophic lateral sclerosis (ALS), upregulation in expression and activity of the ABC transporter P-glycoprotein (P-gp) driven by disease advancement progressively reduces CNS penetration and efficacy of the ALS drug, riluzole. Post-mortem spinal cord tissues from ALS patients revealed elevated P-gp expression levels in endothelial cells of the blood-spinal cord barrier compared to levels measured in control, non-diseased individuals. We recently found that astrocytes expressing familial ALS-linked SOD1 mutations regulate expression levels of P-gp in endothelial cells, which also exhibit a concomitant, significant increase in reactive oxygen species production and NFκB nuclear translocation when exposed to mutant SOD1 astrocyte conditioned media. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.expneurol.2019.04.002DOI Listing
April 2019
1 Read
4.696 Impact Factor

A Novel Pharyngeal Clearance Maneuver for Initial Tracheostomy Tube Cuff Deflation in High Cervical Tetraplegia.

Am J Phys Med Rehabil 2019 Apr 9. Epub 2019 Apr 9.

Rehabilitation Research Center at Santa Clara Valley Medical Center, San Jose, CA.

Mechanical insufflation-exsufflation (MIE), or "cough-assist" is a commonly used method of clearing tracheal and pulmonary secretions in patients with respiratory insufficiency secondary to spinal cord injury (SCI). This report presents a novel technique termed the Pharyngeal Clearance Maneuver (PCM) which utilizes a modified application of the MIE device to mobilize "secretion burden" at the portion of the trachea above the tracheostomy cuff during cuff deflation. Utilization of this strategy may reduce the risk of aspiration, infection, and respiratory compromise for patients with high cervical SCI in the acute rehabilitation setting. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PHM.0000000000001192DOI Listing
April 2019
1 Read

Air contamination during medical treatment results in deposits of microemboli in the lungs: An autopsy study.

Int J Artif Organs 2019 Apr 11:391398819840363. Epub 2019 Apr 11.

2 Department of Public Health and Clinical Medicine, Faculty of Medicine, Umeå University, Umeå, Sweden.

Introduction: Microbubbles of air may enter into patients during conventional hemodialysis, infusions of fluids, or by injections. The aim of this study was to investigate whether the air that enters the patient during hemodialysis can be detected in the lungs after death, and if so, whether this may be related to tissue damage.

Methods: The material consisted of lung tissue from five chronic hemodialysis patients who died either during (two) or after hemodialysis (range 10 min from start until 3333 min after the last hemodialysis session); as reference group tissue was taken from seven patients who died due to amyotrophic lateral sclerosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0391398819840363DOI Listing
April 2019
1 Read

Predictors of amyotrophic lateral sclerosis mimic syndrome.

Acta Neurol Belg 2019 Apr 10. Epub 2019 Apr 10.

ALS Clinic, Neurology Department, Hospital Ramos Mejía, Gral. Urquiza 609, Zip 1221 ADC, Buenos Aires, Argentina.

The term amyotrophic lateral sclerosis mimic syndrome (ALSms) includes pathologies that present signs or symptoms similar to those caused by amyotrophic lateral sclerosis (ALS), which can lead to misdiagnosis. In general, any kind of misdiagnosis can result in negative clinical, psychological and economic consequences as well diagnostic and treatment delay. The objectives were to determine the frequency and to compare the demographic and clinical characteristics of patients with ALS and ALSms in our ALS clinic. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13760-019-01135-1DOI Listing
April 2019
1 Read

ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis.

Front Neurol 2019 27;10:293. Epub 2019 Mar 27.

Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.

Disease-modifying therapies for amyotrophic lateral sclerosis (ALS) are still not satisfactory. The Rho kinase (ROCK) inhibitor fasudil has demonstrated beneficial effects in cell culture and animal models of ALS. For many years, fasudil has been approved in Japan for the treatment of vasospasm in patients with subarachnoid hemorrhage with a favorable safety profile. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fneur.2019.00293DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446974PMC
March 2019
1 Read

Repurposing of the β-Lactam Antibiotic, Ceftriaxone for Neurological Disorders: A Review.

Front Neurosci 2019 26;13:236. Epub 2019 Mar 26.

Department of Pharmacology and Toxicology, School of Pharmacy, College of Health Sciences, Mekelle University, Mekelle, Ethiopia.

To date, there is no cure or disease-modifying agents available for most well-known neurological disorders. Current therapy is typically focused on relieving symptoms and supportive care in improving the quality of life of affected patients. Furthermore, the traditional drug discovery technique is more challenging, particularly for neurological disorders. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fnins.2019.00236DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444273PMC
March 2019
2 Reads

Tracheotomy in Amyotrophic Lateral Sclerosis: The Argument in Favor.

Arch Bronconeumol 2019 Apr 7. Epub 2019 Apr 7.

Servicio de Neumología, Hospital Clínico Universitario, Valencia, España; Instituto Investigación Sanitaria INCLIVA, Valencia, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.arbres.2018.11.007DOI Listing
April 2019
1 Read

[Jean-Martin Charcot, discovery and nomenclature of amyotrophic lateral sclerosis].

Authors:
Y L Ma Z P Li

Zhonghua Yi Shi Za Zhi 2019 Jan;49(1):14-18

Department of Medical History, School of Basic Medicine Sciences, Harbin Medical University, Harbin 150086, China.

In the 19th century, neurologists discovered a series of diseases characterized by limb weakness and muscle atrophy, but it was not certain whether they were variants of the same disease or completely different diseases. In 1869, Jean-Martin Charcot first diagnosed the disease, and began to use the term "amyotrophic lateral sclerosis" in 1874. The disease is also known as "Lou Gehrig's disease" in the United States, "Charcot's disease" in France, and "Motor Neuron Disease (MND)" in UK. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.0255-7053.2019.01.003DOI Listing
January 2019
1 Read

Aberrant Phase Transitions: Side Effects and Novel Therapeutic Strategies in Human Disease.

Front Genet 2019 22;10:173. Epub 2019 Mar 22.

University of Rome "Foro Italico", Rome, Italy.

Phase separation is a physiological process occurring spontaneously when single-phase molecular complexes separate in two phases, a concentrated phase and a more diluted one. Eukaryotic cells employ phase transition strategies to promote the formation of intracellular territories not delimited by membranes with increased local RNA concentration, such as nucleolus, paraspeckles, P granules, Cajal bodies, P-bodies, and stress granules. These organelles contain both proteins and coding and non-coding RNAs and play important roles in different steps of the regulation of gene expression and in cellular signaling. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fgene.2019.00173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440380PMC
March 2019
2 Reads

Ethical Principles in Patient-Centered Medical Care to Support Quality of Life in Amyotrophic Lateral Sclerosis.

Front Neurol 2019 22;10:259. Epub 2019 Mar 22.

Department of Neurology, University of Ulm, Ulm, Germany.

It is one of the primary goals of medical care to secure good quality of life (QoL) while prolonging survival. This is a major challenge in severe medical conditions with a prognosis such as amyotrophic lateral sclerosis (ALS). Further, the definition of QoL and the question whether survival in this severe condition is compatible with a good QoL is a matter of subjective and culture-specific debate. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fneur.2019.00259DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439311PMC
March 2019
1 Read

Small molecule targeting of RNA structures in neurological disorders.

Ann N Y Acad Sci 2019 Apr 9. Epub 2019 Apr 9.

Department of Chemistry, The Scripps Research Institute, Jupiter, Florida.

Aberrant RNA structure and function operate in neurological disease progression and severity. As RNA contributes to disease pathology in a complex fashion, that is, via various mechanisms, it has become an attractive therapeutic target for small molecules and oligonucleotides. In this review, we discuss the identification of RNA structures that cause or contribute to neurological diseases as well as recent progress toward the development of small molecules that target them, including small molecule modulators of pre-mRNA splicing and RNA repeat expansions that cause microsatellite disorders such as Huntington's disease and amyotrophic lateral sclerosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/nyas.14051DOI Listing
April 2019
1 Read

Targeting Macrophage for the Treatment of Amyotrophic Lateral Sclerosis.

CNS Neurol Disord Drug Targets 2019 Apr 8. Epub 2019 Apr 8.

Translational Center for Stem Cell Research, Tongji Hospital, Stem Cell Research Center, Tongji University School of Medicine, Shanghai. China.

Amyotrophic lateral sclerosis is a progressive neurodegenerative disease that specifically affects motor neurons in the brain and in the spinal cord. Patients with amyotrophic lateral sclerosis usually die from respiratory failure within 3 to 5 years from when the symptoms first appear. Currently, there is no cure for amyotrophic lateral sclerosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1871527318666190409103831DOI Listing
April 2019
2 Reads

Plasma creatinine and amyotrophic lateral sclerosis prognosis: a systematic review and meta-analysis.

Amyotroph Lateral Scler Frontotemporal Degener 2019 Apr 9:1-8. Epub 2019 Apr 9.

a UMR 1253, Team 2, INSERM/University of Tours , Tours , France and.

Background: Plasma creatinine has been described as a prognostic biomarker for Amyotrophic Lateral Sclerosis (ALS), but with conflicting results in the literature. We performed a systematic review followed by a meta-analysis to address this question.

Methods: We performed a systematic review of Pubmed, Embase and Cochrane databases and retrieved 14 distinct cohorts (19 studies) reporting results regarding the relationship between plasma creatinine and a clinical marker for ALS progression, notably ALSFRS (ALS Functional Rating Scale) and survival. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21678421.2019.1572192DOI Listing
April 2019
1 Read

Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models.

J Vis Exp 2019 Mar 24(145). Epub 2019 Mar 24.

Chemistry Department, Brooklyn College; Ph.D. Programs in Chemistry, Biochemistry, and Biology, Graduate Center of the City University of New York;

Neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD), cause the loss of hundreds of thousands of lives each year. Effective treatment options able to halt disease progression are lacking. Despite the extensive sequencing efforts in large patient populations, the majority of ALS and PD cases remain unexplained by genetic mutations alone. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3791/59104DOI Listing
March 2019
1 Read

Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis?

Stem Cells Int 2019 10;2019:3675627. Epub 2019 Mar 10.

IRCCS Centro Neurolesi "Bonino Pulejo", 98124 Messina, Italy.

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the degeneration of both upper and lower motor neurons. Patients show both motor and extra-motor symptoms. A cure is not available at this time, and the disease leads to death within 3-5 years, mainly due to respiratory failure. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/3675627DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431432PMC
March 2019
1 Read

Distal myopathy and rapidly progressive dementia associated with a novel mutation in the VCP gene: Expanding inclusion body myopathy with early-onset Paget disease and frontotemporal dementia spectrum.

J Clin Neurosci 2019 Apr 4. Epub 2019 Apr 4.

Department of Neurosciences and Mental Health, Centro Hospitalar Universitário de Lisboa-Norte, Lisbon, Portugal; Instituto de Medicina Molecular and Instituto de Fisiologia, Faculdade de Medicina, Universidade de Lisboa, Portugal.

Distal myopathies are a clinically and genetically heterogeneous group characterized by distal weakness at onset. Distal myopathies are classified according to age of onset, inheritance pattern, clinical features and molecular diagnosis. Inclusion body myopathy with early-onset Paget disease and fronto-temporal dementia is a rare adult late-onset disease related to valosin-containing protein gene mutations with an autosomal dominance inheritance. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2019.03.063DOI Listing
April 2019
1 Read

An FTLD-associated SQSTM1 variant impacts Nrf2 and NF-κB signalling and is associated with reduced phosphorylation of p62.

Mol Cell Neurosci 2019 Apr 4. Epub 2019 Apr 4.

Harry Perkins Institute of Medical Research, University of Western Australia, Nedlands, Western Australia, Australia; Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. Electronic address:

Elevated oxidative stress has been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS) and Frontotemporal Lobar Degeneration (FTLD). In response to oxidative stress, the Nrf2 transcription factor activates protective antioxidant genes. A critical regulator of Nrf2 is the inhibitory protein Keap1, which mediates Nrf2 degradation. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10447431183036
Publisher Site
http://dx.doi.org/10.1016/j.mcn.2019.04.001DOI Listing
April 2019
5 Reads

Telemedicine in Rehabilitation.

Phys Med Rehabil Clin N Am 2019 05 5;30(2):473-483. Epub 2019 Mar 5.

Department of Spinal Cord Injury and Disorder, Amyotrophic Lateral Sclerosis Program, Multiple Sclerosis Regional Center, The James J Peters VAMC, SCI/D Unit, 130 West Kingsbridge Road, Bronx, NY 10468, USA. Electronic address:

Telerehabilitation refers to the virtual delivery of rehabilitation services into the patient's home. This methodology has shown to be advantageous when used to enhance or replace conventional therapy to overcome geographic, physical, and cognitive barriers. The exponential growth of technology has led to the development of new applications that enable health care providers to monitor, educate, treat, and support patients in their own environment. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10479651183086
Publisher Site
http://dx.doi.org/10.1016/j.pmr.2018.12.002DOI Listing
May 2019
6 Reads

The metastability of the proteome of spinal motor neurons underlies their selective vulnerability in ALS.

Neurosci Lett 2019 Apr 3;704:89-94. Epub 2019 Apr 3.

Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, UK.

Amyotrophic lateral sclerosis (ALS) is a heterogeneous motor neuron disease with familial forms linked to numerous mutations in a range of genes. The resulting variant proteins, including SOD1, TDP-43, and FUS, disturb protein homeostasis in a variety of ways and lead to the formation of intracellular inclusion bodies that are characteristic of different neuropathological subtypes of the disease. These inclusions are made up of scores of proteins that do not appear at first to share obvious characteristics other than coaggregation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2019.04.001DOI Listing

Dynamic interplay between H-current and M-current controls motoneuron hyperexcitability in amyotrophic lateral sclerosis.

Cell Death Dis 2019 Apr 5;10(4):310. Epub 2019 Apr 5.

School of Chemistry and Molecular Bioscience, University of Wollongong, Northfields Avenue, Wollongong, NSW, 2522, Australia.

Amyotrophic lateral sclerosis (ALS) is a type of motor neuron disease (MND) in which humans lose motor functions due to progressive loss of motoneurons in the cortex, brainstem, and spinal cord. In patients and in animal models of MND it has been observed that there is a change in the properties of motoneurons, termed neuronal hyperexcitability, which is an exaggerated response of the neurons to a stimulus. Previous studies suggested neuronal excitability is one of the leading causes for neuronal loss, however the factors that instigate excitability in neurons over the course of disease onset and progression are not well understood, as these studies have looked mainly at embryonic or early postnatal stages (pre-symptomatic). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41419-019-1538-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450866PMC
April 2019
2 Reads

Vowel-Specific Intelligibility and Acoustic Patterns in Individuals With Dysarthria Secondary to Amyotrophic Lateral Sclerosis.

J Speech Lang Hear Res 2019 Jan;62(1):34-59

Department of Neurology, The Pennsylvania State University College of Medicine, Hershey.

Purpose The purpose of the study was to investigate vowel-specific intelligibility and acoustic patterns of individuals with different severities of dysarthria secondary to amyotrophic lateral sclerosis (ALS). Method Twenty-three individuals with dysarthria secondary to ALS and 22 typically aging individuals participated as speakers. Participants with ALS were divided into 2 severity groups (severe, mild). Read More

View Article

Download full-text PDF

Source
http://pubs.asha.org/doi/10.1044/2018_JSLHR-S-17-0357
Publisher Site
http://dx.doi.org/10.1044/2018_JSLHR-S-17-0357DOI Listing
January 2019
2 Reads

Effects of Curcumin on Microglial Cells.

Neurotox Res 2019 Apr 4. Epub 2019 Apr 4.

Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Microglia are innate immune system cells which reside in the central nervous system (CNS). Resting microglia regulate the homeostasis of the CNS via phagocytic activity to clear pathogens and cell debris. Sometimes, however, to protect neurons and fight invading pathogens, resting microglia transform to an activated-form, producing inflammatory mediators, such as cytokines, chemokines, iNOS/NO and cyclooxygenase-2 (COX-2). Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12640-019-00030-0
Publisher Site
http://dx.doi.org/10.1007/s12640-019-00030-0DOI Listing
April 2019
7 Reads

Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study.

J Neurol 2019 Apr 4. Epub 2019 Apr 4.

Department of Neuroscience "Rita Levi Montalcini", Movement Disorders Center, University of Turin, Turin, Italy.

Background: Amyotrophic lateral sclerosis (ALS) is characterized by a spectrum of phenotypes, but only a few studies have addressed the presence of parkinsonian (PK) symptoms. The aim of our study was to investigate the occurrence of PK features in a prospective population-based cohort of ALS patients, determining their demographic, clinical, neuropsychological and genetic characteristics, and identifying their morphological and functional imaging correlates.

Methods: A consecutive series of ALS patients were enrolled and prospectively followed for 2 years. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00415-019-09305-0
Publisher Site
http://dx.doi.org/10.1007/s00415-019-09305-0DOI Listing
April 2019
2 Reads

Pathological Crying and Laughing in Motor Neuron Disease: Pathobiology, Screening, Intervention.

Front Neurol 2019 21;10:260. Epub 2019 Mar 21.

Computational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.

Pathological crying and laughing (PCL) has significant quality-of-life implications in amyotrophic lateral sclerosis (ALS); it can provoke restrictive life-style modifications and lead to social isolation. Despite its high prevalence and quality of life implications, it remains surprisingly understudied. Divergent pathophysiological models have been proposed, centered on corticobulbar tract degeneration, prefrontal cortex pathology, sensory deafferentation, and impaired cerebellar gate-control mechanisms. Read More

View Article

Download full-text PDF

Source
https://www.frontiersin.org/article/10.3389/fneur.2019.00260
Publisher Site
http://dx.doi.org/10.3389/fneur.2019.00260DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438102PMC
March 2019
3 Reads

Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis.

Science 2019 04;364(6435):89-93

Center for Genomics of Neurodegenerative Disease, New York Genome Center, New York, NY, USA.

Paralysis occurring in amyotrophic lateral sclerosis (ALS) results from denervation of skeletal muscle as a consequence of motor neuron degeneration. Interactions between motor neurons and glia contribute to motor neuron loss, but the spatiotemporal ordering of molecular events that drive these processes in intact spinal tissue remains poorly understood. Here, we use spatial transcriptomics to obtain gene expression measurements of mouse spinal cords over the course of disease, as well as of postmortem tissue from ALS patients, to characterize the underlying molecular mechanisms in ALS. Read More

View Article

Download full-text PDF

Source
http://www.sciencemag.org/lookup/doi/10.1126/science.aav9776
Publisher Site
http://dx.doi.org/10.1126/science.aav9776DOI Listing
April 2019
6 Reads

Phase separation of RNA-binding proteins in physiology and disease: An introduction to the JBC Reviews thematic series.

Authors:
James Shorter

J Biol Chem 2019 04 4. Epub 2019 Apr 4.

University of Pennsylvania, United States.

In recent years, there has been a jarring awakening that liquid-liquid phase separation (LLPS) of key protein and nucleic acid scaffolds underpins the biogenesis of diverse membraneless organelles, including P granules and stress granules in the cytoplasm, and, nucleoli and paraspeckles in the nucleus. These biomolecular condensates are proposed to be critical organizers of subcellular biochemistry and to control the flow of information from genotype to phenotype. Despite clear biological utility, LLPS can also have deleterious outcomes. Read More

View Article

Download full-text PDF

Source
http://www.jbc.org/lookup/doi/10.1074/jbc.REV119.007944
Publisher Site
http://dx.doi.org/10.1074/jbc.REV119.007944DOI Listing
April 2019
3 Reads

Phosphorylated NF-κB subunit p65 aggregates in granulovacuolar degeneration and neurites in neurodegenerative diseases with tauopathy.

Neurosci Lett 2019 Apr 1. Epub 2019 Apr 1.

Department of Neurology, Kyoto University Graduate School of Medicine, Japan. Electronic address:

Granulovacuolar degeneration (GVD) was originally reported in Alzheimer's disease (AD) and later found in aging brains. Pathologically, GVD is thought to be associated with the development of tauopathy, but the precise mechanism remains unknown. Previous studies have suggested that GVD contains proteins associated with an inflammatory signal. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03043940193019
Publisher Site
http://dx.doi.org/10.1016/j.neulet.2019.03.036DOI Listing
April 2019
4 Reads